S09
Newer trends in the evaluation of
hyperlipoproteinaemias
Wednesday 10:30- 12:45
Chair: Peter Nilsson-Ehle
Co-chair: AnneTybjaerg-Hansen
Terje Pedersen
Hyperlipoproteinernia as part of a cardiovascular
risk profile: rationale for international and
national guidelines
Peter Nilsson-Ehle
Hyperlipoproteinemi as part of a cardiovascular
risk profile: rationale for intematinal and national
guidelines
SeppoYlä-Hertualla
Oxidized LDL and its clinical relevance
Anne Tybjcerg-Hansen
Gene aberrations in hyperlipoproteinernia
SlO
New analyses in the evaluation ofheart failure
Wednesday 14:45 - 17:00
Chair: Christian Hall
Co-chair: Oddvar Stokke
Heikki Ruskoaho
Natriuretic peptides. What, when and how?
Christian Hall
Natriuretic peptides as markers of cardiac function
HenrikHolmström
Application of natriuretic peptide measurements
in pediatric cardiology
TheresaAMcDonagh
Should we use natriuretic peptide measurements
to screen for asymptomatic heart failure?
Sll
Laboratorymedicine in primary health care
Wednesday 14:45- 17:00
Chair: Nils Tryding
Co-chair: Sverre Sandberg
Sverre Sandberg
Quality assurance of test requesting, test analysing
and interpretation of test results in primary health
care.
Ivan Brandslund
The use ofCRP in primary health care, clinical,
organisational and economical aspects.
GeirThue
Helicobacter pylori:Medical decisions based on
different test results.
Klinisk Kjemi
i
Norden l, 2000
Siri Fauli
Helicobacter Pylori: Economical consequences of
medical decisions.
Nils Tryding
Towards optimal use of clinical chemistry in
primary care- experiences from Sweden
S12
Managing the changes in laboratorymedicine
Thursday 10:30- 12:45
Chair: Risto Heikkinen
IanWilkinson
Change in the field - change in the mind
Torben 0mtoft
Managing basic research within a routine
laboratory
Michael Mayer
Laboratory alliance era - Time for improved
presentation of test results
0yvind Fylling Jensen
Managing technology change in a service
laboratory
Risto Heikkinen
Expected and realized financial benefits of
consolidatian and mergers
S13
Diabetes
Thursday 10:30- 12:45
Chair: Jan-Olof Jeppson
Jan-Olof Jeppson
Biochemical basis ofHbAlc and its clinica1 utility
LeifGroop
Genetic camplexity of diabetes
Per Femlund
Autoimmune markers
Knut Borch-Johnsen
The epidemic of type 2diabetes:Diagnostic,
therapeutical and public health challenges
15
